Latest operating income for BDR: $-1.9M.
Get informed when a big investor buys or sells
+ FollowAs of Dec 31, 2022
Trailing 12 months ending Dec 31, 2022
As of the most recent data (December 2022), BDR shows a operating income of $-1.9M. That compares with $-4.5M in the prior-year period — up 56.6% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, BDR's operating income is now $-1.9M (was $-4.5M) — a 56.6% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Blonder Tongue Laboratories is outperforming or lagging.
Tracking BDR's operating income over time shows whether Blonder Tongue Laboratories is scaling, shrinking, or reshaping that part of the business. The current reading is $-1.9M That compares with $-4.5M in the prior-year period — up 56.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this operating income page, Stockcircle has Blonder Tongue Laboratories's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect operating income (currently $-1.9M) with ownership activity and broader fundamentals.
Blonder Tongue Laboratories's operating income is $-1.9M; compare it with other Technology names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.